Project Number 5R44AG071409-02 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 2. Imaging Biomarkers c. PET Other Imaging Researcher and Organization Principal Investigator ELIZAROV, ARKADIJ Principal Investigator First Name ARKADIJ Principal Investigator Last Name ELIZAROV Awardee Organization TRACE-ABILITY, INC. Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $1,252,101 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official LUO, YUAN
